These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19380600)

  • 1. Piperaquine pharmacodynamics and parasite viability in a murine malaria model.
    Moore BR; Ilett KF; Page-Sharp M; Jago JD; Batty KT
    Antimicrob Agents Chemother; 2009 Jul; 53(7):2707-13. PubMed ID: 19380600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of piperaquine in a murine malaria model.
    Moore BR; Batty KT; Andrzejewski C; Jago JD; Page-Sharp M; Ilett KF
    Antimicrob Agents Chemother; 2008 Jan; 52(1):306-11. PubMed ID: 17984231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the parasite killing effect of artemisinin combination therapy in a murine malaria model.
    Patel K; Batty KT; Moore BR; Gibbons PL; Kirkpatrick CM
    J Antimicrob Chemother; 2014 Aug; 69(8):2155-63. PubMed ID: 24777899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fitness cost of resistance for lumefantrine and piperaquine-resistant Plasmodium berghei in a mouse model.
    Gimode WR; Kiboi DM; Kimani FT; Wamakima HN; Burugu MW; Muregi FW
    Malar J; 2015 Jan; 14():38. PubMed ID: 25627576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of Piperaquine to Its Antiplasmodial Metabolites and Their Pharmacokinetic Profiles in Healthy Volunteers.
    Liu H; Zhou H; Cai T; Yang A; Zang M; Xing J
    Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29784841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium berghei ANKA: selection of resistance to piperaquine and lumefantrine in a mouse model.
    Kiboi DM; Irungu BN; Langat B; Wittlin S; Brun R; Chollet J; Abiodun O; Nganga JK; Nyambati VC; Rukunga GM; Bell A; Nzila A
    Exp Parasitol; 2009 Jul; 122(3):196-202. PubMed ID: 19318094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling Prevention of Malaria and Selection of Drug Resistance with Different Dosing Schedules of Dihydroartemisinin-Piperaquine Preventive Therapy during Pregnancy in Uganda.
    Wallender E; Zhang N; Conrad M; Kakuru A; Muhindo M; Tumwebaze P; Kajubi R; Mota D; Legac J; Jagannathan P; Havlir D; Kamya M; Dorsey G; Aweeka F; Rosenthal PJ; Savic RM
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30530597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent studies on antimalarial efficacy of piperaquine and hydroxypiperaquine.
    Chen L
    Chin Med J (Engl); 1991 Feb; 104(2):161-3. PubMed ID: 1874015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperaquine and Lumefantrine resistance in Plasmodium berghei ANKA associated with increased expression of Ca2+/H+ antiporter and glutathione associated enzymes.
    Kiboi D; Irungu B; Orwa J; Kamau L; Ochola-Oyier LI; Ngángá J; Nzila A
    Exp Parasitol; 2014 Dec; 147():23-32. PubMed ID: 25448357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacodynamics of doxycycline in a murine malaria model.
    Batty KT; Law AS; Stirling V; Moore BR
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4477-9. PubMed ID: 17876000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of malaria-induced alteration of metabolism on piperaquine disposition in Plasmodium yoelii infected mice and predicted in malaria patients.
    Xie Y; Zhang Y; Lin F; Chen X; Xing J
    Int J Antimicrob Agents; 2024 Jul; 64(1):107209. PubMed ID: 38761871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced antimalarial effects of chloroquine by aqueous Vernonia amygdalina leaf extract in mice infected with chloroquine resistant and sensitive Plasmodium berghei strains.
    Iwalokun BA
    Afr Health Sci; 2008 Mar; 8(1):25-35. PubMed ID: 19357729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450 2D-mediated metabolism is not necessary for tafenoquine and primaquine to eradicate the erythrocytic stages of Plasmodium berghei.
    Milner EE; Berman J; Caridha D; Dickson SP; Hickman M; Lee PJ; Marcsisin SR; Read LT; Roncal N; Vesely BA; Xie LH; Zhang J; Zhang P; Li Q
    Malar J; 2016 Dec; 15(1):588. PubMed ID: 27923405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the prophylactic activity and pharmacokinetic profile of oral tafenoquine compared to primaquine for inhibition of liver stage malaria infections.
    Li Q; O'Neil M; Xie L; Caridha D; Zeng Q; Zhang J; Pybus B; Hickman M; Melendez V
    Malar J; 2014 Apr; 13():141. PubMed ID: 24731238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semimechanistic Pharmacokinetic and Pharmacodynamic Modeling of Piperaquine in a Volunteer Infection Study with Plasmodium falciparum Blood-Stage Malaria.
    Wattanakul T; Baker M; Mohrle J; McWhinney B; Hoglund RM; McCarthy JS; Tarning J
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33468477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infectivity and Screening of Anti-piperaquine Genes in Mice Infected with Piperaquine-Sensitive and Piperaquine-Resistant Plasmodium berghei.
    Yi G; Zhou L; Ye Z; Huang X; Lu F; Guo H
    Acta Parasitol; 2019 Sep; 64(3):670-678. PubMed ID: 31321598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disordered Metabolic Profiling in Plasma and Tissues of Mice Infected with Artemisinin-Sensitive and -Resistant Plasmodium berghei K173 Determined by
    Chen J; Zhang J; Wu X; Chen J; Dai Y; Ma X; Yu Y; Zhang L; Liu C
    J Proteome Res; 2019 May; 18(5):1970-1993. PubMed ID: 30931571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based model of parasite growth and dihydroartemisinin pharmacodynamics in murine malaria.
    Patel K; Batty KT; Moore BR; Gibbons PL; Bulitta JB; Kirkpatrick CM
    Antimicrob Agents Chemother; 2013 Jan; 57(1):508-16. PubMed ID: 23147722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scalable preparation and differential pharmacologic and toxicologic profiles of primaquine enantiomers.
    Nanayakkara NP; Tekwani BL; Herath HM; Sahu R; Gettayacamin M; Tungtaeng A; van Gessel Y; Baresel P; Wickham KS; Bartlett MS; Fronczek FR; Melendez V; Ohrt C; Reichard GA; McChesney JD; Rochford R; Walker LA
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4737-44. PubMed ID: 24913163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Studies on piperaquine as long-acting antimalarial drug against Plasmodium berghei in mice].
    Zhu DQ; Dai ZR; Li JC; Jiang ZK
    Yao Xue Xue Bao; 1982 Dec; 17(12):894-8. PubMed ID: 6763837
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.